ID   Hepama-1
AC   CVCL_IR43
SY   HP-1
DR   CCRID; 4201PAT-CCTCC00131
DR   CCRID; 4201PAT-CCTCC00145
DR   Wikidata; Q54882832
RX   Patent=CN1114619C;
RX   PubMed=1849045;
RX   PubMed=2424200;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C95013.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human hepatocellular carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
RX   Patent=CN1114619C;
RA   Xie H., Dai X.-L., Wang G.-F., Liang M., Zhang R.-P., Wang F.,
RA   Chen Z.-J.;
RT   "Liver cancer murine monoclonal antibody without endogenous
RT   immunoglobulin and its preparation and application.";
RL   Patent number CN1114619C, 16-Jul-2003.
//
RX   PubMed=1849045;
RA   Fuhrer J.P., Xie H., Murphy M.J. Jr., Ye J.N., Yao Z.;
RT   "Characterization of a membrane-associated glycoprotein (gp 43) on
RT   human hepatocellular carcinoma by a monoclonal antibody.";
RL   Cancer Res. 51:2158-2163(1991).
//
RX   PubMed=2424200;
RA   Xie H., Yang Z.-H., Chen R.-M., Yao Z., Wang B.-M., Guo S.-Y.,
RA   Yan Z.-F.;
RT   "Two mouse hybridomas secreting monoclonal antibodies against human
RT   liver carcinoma and their antibody specificity.";
RL   Shi Yan Sheng Wu Xue Bao 18:263-273(1985).
//